Scientific article

Accès à l’insuline : le(s) rôle(s) des gouvernements

Other titleAccess to insulin: The role(s) of governments
Published inMédecine des maladies métaboliques, vol. 17, no. 4, p. 335-341
Publication date2023-06
First online date2023-05-23

Access to insulin is complex requiring global and national factors to be considered. The World Health Organization (WHO) proposes a framework to disentangle this. This includes: research & development and innovation; manufacturing; regulatory aspects; selection, pricing and reimbursement; procurement and supply; prescribing; dispensing; and use. For each of these, governments can play an essential role in guaranteeing an adequate allocation of resources as well as ensuring that diabetes care is properly structured within health systems. Concerted action is needed to guarantee access to affordable insulin and care and to ensure that the various needs of people with diabetes are included in government programs and interventions. Governments also have a role to play in being a counterweight to the private sector, working closely to establish networks and possibilities for exchanges between different actors including the civil society.

  • Insuline
  • Systèmes de santé
  • Politiques de santé
  • Accès aux systèmes de santé
  • Gouvernement
  • Insulin
  • Health systems
  • Health policies
  • Access to health systems
  • Government
Citation (ISO format)
BERAN, David Henri, BESANÇON, Stéphane. Accès à l’insuline : le(s) rôle(s) des gouvernements. In: Médecine des maladies métaboliques, 2023, vol. 17, n° 4, p. 335–341. doi: 10.1016/j.mmm.2023.05.004
Main files (1)
Article (Published version)
ISSN of the journal1957-2557

Technical informations

Creation08/15/2023 7:59:52 AM
First validation04/05/2024 11:37:32 AM
Update time04/05/2024 11:37:32 AM
Status update04/05/2024 11:37:32 AM
Last indexation05/06/2024 6:19:36 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack